CRISPR NEWS

China: Patent granted to Doudna-Charpentier

In June 2017, China’s State Intellectual Property Office awarded a broad CRISPR-Cas9 patent to the Doudna-Charpentier team covering the single-guide RNA format of the CRISPR-Cas9 system and its use in any environment (including plant, animal and human cells). The Chinese patent also includes claims covering the use of CRISPR-Cas9 in producing medicines for treating disease.

 

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
Read moreArrow-down